Goodman Advisory Group, LLC Kiniksa Pharmaceuticals, Ltd. Transaction History
Goodman Advisory Group, LLC
- $249 Million
- Q1 2025
A detailed history of Goodman Advisory Group, LLC transactions in Kiniksa Pharmaceuticals, Ltd. stock. As of the latest transaction made, Goodman Advisory Group, LLC holds 1,363 shares of KNSA stock, worth $36,760. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,363Holding current value
$36,760% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding KNSA
# of Institutions
9Shares Held
1.93MCall Options Held
0Put Options Held
0-
Pictet Asset Management Sa Geneva 73, V81.52MShares$40.9 Million0.03% of portfolio
-
Spearhead Capital Advisors, LLC Wellington, FL203KShares$5.46 Million2.82% of portfolio
-
Harbor Capital Advisors, Inc.77.7KShares$2.1 Million0.08% of portfolio
-
Putnam Investments LLC Boston, MA39.5KShares$1.06 Million0.0% of portfolio
-
Birchview Capital, LP Burlington, VT30KShares$809,1000.51% of portfolio
About Kiniksa Pharmaceuticals, Ltd.
- Ticker KNSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,470,400
- Market Cap $930M
- Description
- Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...